Merck Kgaa
Entity.
- Evidence
- 26 documents · 15 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 10 Sept 2026, last seen 5 Nov 2026
- Measured
- 27% of mentions say something specific about it; the rest only name it
- As of
- 6 Nov 2026
Where this comes from
- GEN · 2026-11-04 · Lonza Expanding U.S. CDMO Footprint with Purchase of Five Merck KGaA Sites (opens the source in a new tab)
- Bioxconomy · 2026-11-03 · Portfolio reshuffle: Lonza buys Merck KGaA's CDMO arm (opens the source in a new tab)
- Endpoints News · 2026-11-03 · Merck KGaA to exit CDMO business, divesting US sites to Lonza (opens the source in a new tab)
- Chemical Engineering · 2026-11-03 · Merck KGaA to divest CDMO business to Lonza (opens the source in a new tab)
- Chemical & Engineering News · 2026-11-03 · Lonza to buy Merck KGaA’s contract manufacturing business (opens the source in a new tab)
- BioSpace · 2026-11-03 · Lonza agrees to buy 5 Merck KGaA facilities to accelerate US expansion (opens the source in a new tab)
- Endpoints News · 2026-10-19 · Merck KGaA to buy Silence Therapeutics and its siRNA pipeline for $1.3B (opens the source in a new tab)
- BioPharma Dive · 2026-10-19 · Merck KGaA bets on RNAi with $1.3B Silence buyout (opens the source in a new tab)
- Fierce Biotech · 2026-10-13 · Merck KGaA spinout iOnctura touts PI3K delta inhibitor in metastatic eye cancer (opens the source in a new tab)
- Chemical & Engineering News · 2026-09-10 · Merck KGaA buys PostEra’s oral fertility molecules (opens the source in a new tab)
What is claimed about it
- Corroborated: Reported by three or more sources that did not copy each other.
- Lonza Expanding U.S. CDMO Footprint with Purchase of Five Merck KGaA Sites Corroborated · first reported 3 Nov 2026